Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Mylan gets FDA nod for cost-saving HIV combo

The U.S. FDA approved Mylan’s Symfi (efavirnenz, lamivudine and tenofovir disoproxil fumarate), a triple combo once-daily HIV treatment for adult and pediatric patients who weigh at least 88 lbs.

This marks the third HIV approval for Mylan. The approval of Symfi comes after the FDA's recent approval of two Mylan antiretrovirals (ARVs): Cimduo (lamivudine and tenofovir disoproxil fumarate) and Symfi Lo (efavirenz, lamivudine and tenofovir disoproxil fumarate).

Efavirenz tablets are a generic form of Bristol-Myers Squibb’s Sustiva. Lamivudine tablets are the generic version of ViiV Healthcare's Epivir.

According to Mylan, all ARV regimens are being offered at a significant discount to the price of competing products to bring cost savings to the $20 billion U.S. ARV market.

Apr 2, 2018


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies